<![CDATA[Competition Council]]> https://www.competition.md/ 22.01.2018 en https://www.competition.md/ Copyright (c) 2018 https://www.competition.md/Pfizer hit with record fine after hiking price of NHS epilepsy drug by 2,600pc - costing taxpayer millions <![CDATA[Pfizer hit with record fine after hiking price of NHS epilepsy drug by 2,600pc - costing taxpayer millions // Apropo]]> https://www.competition.md/libview.php?l=en&idc=72&id=5887&t=/Apropo/Pfizer-hit-with-record-fine-after-hiking-price-of-NHS-epilepsy-drug-by-2600pc-costing-taxpayer-millions/  By Press Association  7 DECEMBER 2016 • 8:45AM Drug firms Pfizer and Flynn Pharma have been fined nearly £90m for "excessive and unfair" pricing to the NHS after hiking the cost of an anti-epilepsy drug by up to 2,600pc overnight. The Competition and Markets Authority (CMA) said drug maker Pfizer and distributor Flynn Pharma broke competition law when they increased the cost of a medicine used by around 48,000 patients in the UK. The watchdog said their moves saw the cost to the NHS of phenytoin ]]> 09.12.2016 08:45